NYSE - Delayed Quote USD

CONMED Corporation (CNMD)

65.78 +3.88 (+6.27%)
At close: April 26 at 4:00 PM EDT
65.78 0.00 (0.00%)
After hours: April 26 at 4:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,261,549.00
1,244,744.00
1,045,472.00
1,010,635.00
862,459.00
Cost of Revenue
568,660.00
568,499.00
474,227.00
442,599.00
402,159.00
Gross Profit
692,889.00
676,245.00
571,245.00
568,036.00
460,300.00
Operating Expense
549,972.00
555,642.00
501,191.00
458,319.00
414,290.00
Operating Income
142,917.00
120,603.00
70,054.00
109,717.00
46,010.00
Net Non Operating Interest Income Expense
-39,114.00
-39,775.00
-28,905.00
-35,485.00
-44,052.00
Other Income Expense
--
--
-112,011.00
-1,127.00
-355.00
Pretax Income
103,803.00
80,828.00
-70,862.00
73,105.00
1,603.00
Tax Provision
21,454.00
16,369.00
9,720.00
10,563.00
-7,914.00
Net Income Common Stockholders
82,349.00
64,459.00
-80,582.00
62,542.00
9,517.00
Diluted NI Available to Com Stockholders
82,349.00
64,459.00
-80,582.00
62,542.00
9,517.00
Basic EPS
2.68
2.10
-2.68
2.14
0.33
Diluted EPS
2.61
2.04
-2.68
1.94
0.32
Basic Average Shares
30,735.25
30,668.00
30,040.00
29,162.00
28,581.00
Diluted Average Shares
31,565.00
31,548.00
30,040.00
32,216.00
29,464.00
Total Operating Income as Reported
142,917.00
120,603.00
70,054.00
109,717.00
46,010.00
Total Expenses
1,118,632.00
1,124,141.00
975,418.00
900,918.00
816,449.00
Net Income from Continuing & Discontinued Operation
82,349.00
64,459.00
-80,582.00
62,542.00
9,517.00
Normalized Income
82,349.00
64,459.00
-80,582.00
62,542.00
9,517.00
Interest Expense
39,114.00
39,775.00
28,905.00
35,485.00
44,052.00
Net Interest Income
-39,114.00
-39,775.00
-28,905.00
-35,485.00
-44,052.00
EBIT
142,917.00
120,603.00
-41,957.00
108,590.00
45,655.00
EBITDA
214,895.00
192,477.00
27,562.00
179,333.00
118,280.00
Reconciled Cost of Revenue
568,660.00
568,499.00
474,227.00
442,599.00
402,159.00
Reconciled Depreciation
71,978.00
71,874.00
69,519.00
70,743.00
72,625.00
Net Income from Continuing Operation Net Minority Interest
82,349.00
64,459.00
-80,582.00
62,542.00
9,517.00
Normalized EBITDA
214,895.00
192,477.00
27,562.00
179,333.00
118,280.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 7/23/1987

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IART Integra LifeSciences Holdings Corporation
28.34
-0.25%
 
ITGR Integer Holdings Corporation
109.58
-1.41%
 
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
 
NARI Inari Medical, Inc.
38.42
+0.92%
 
PEN Penumbra, Inc.
204.41
-0.53%
 
NVRO Nevro Corp.
11.32
-2.58%
 
IRTC iRhythm Technologies, Inc.
111.91
+0.58%
 
ATEC Alphatec Holdings, Inc.
12.44
+1.63%
 
QDEL QuidelOrtho Corporation
39.64
-0.13%
 
GKOS Glaukos Corporation
99.48
-0.63%